BioCryst Pharmaceuticals, Inc. (BCRX)

7.57 +0.12 (+1.61%) USD  |  NASDAQ  |  Feb 23, 14:09
More

BioCryst Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
KalVista Pharmaceuticals, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Protokinetix, Inc. --